Literature DB >> 49854

Histamine release, formation of prostaglandin-like activity (SRS-C) and mast cell degranulation by the direct lytic factor (DLF) and phospholipase A of cobra venom.

B Damerau, L Lege, H D Oldigs, W Vogt.   

Abstract

Cobra venom, alone and in combination, on mast cell degranulation, histamine release and formation of prostaglandin-like activity (SRS-C) was studied in perfused guinea-pig lungs and in mast cell-containing rat peritoneal cell suspensions. For comparison, the effect of equivalent doses of whole cobra venom was investigated. 1. Cobra venom caused mast cell degranulation, histamine release and SRS-C formation in both systems. For comparable effects much higher doses had to be used in guine-pig lungs than in rat peritoneal cell suspensions. 2. Phase A showed little degranulation of mast cells in both systems, a limited histamine release in rat peritoneal cell suspensions and none in perfused guinea-pig lungs. It caused a considerable SRS-C formation in both, lung tissue and peritoneal cell suspensions. 3. DLF caused histamine release, SRS-C formation and mast cell degranulation in both systems; in rat peritoneal cell suspensions it acted almost as strong as equivalent doses of cobra venom, in guinea pig lungs it was much less active. 4. In rat peritoneal cell suspensions the effects of DLF and phase A in combination did not exceed the sum of their single effects. In guinea-pig lungs these two substances interacted in a potentiating synergism. It is concluded that DLF is the main cytotoxic principle of cobra venom, whereas ph-ase A alone is not cytotoxic. The difference in the synergism of DLF and ph-ase A between rat peritoneal cells and guinea-pig lungs may be due to two different actions of DLF and species differences as regards sensitivity against these actions.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 49854     DOI: 10.1007/bf00510446

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  38 in total

1.  The formation of histamine by fetal rat liver.

Authors:  A BURKHALTER
Journal:  Biochem Pharmacol       Date:  1962 Apr-May       Impact factor: 5.858

2.  Isolation of "biologically intact" mast cells.

Authors:  B UVNAS; I L THON
Journal:  Exp Cell Res       Date:  1959-11       Impact factor: 3.905

3.  [Manometric determination of phospholipase A].

Authors:  E HABERMANN
Journal:  Biochem Z       Date:  1957

4.  Simple procedure for identification and rapid counting of mast cells in tissue sections.

Authors:  E W SMITH; W B ATKINSON
Journal:  Science       Date:  1956-05-25       Impact factor: 47.728

5.  Comparison of histamine release by compound 48/80 and octylamine in perfused tissues.

Authors:  W FELDBERG; J L MONGAR
Journal:  Br J Pharmacol Chemother       Date:  1954-06

6.  Liberation of histamine and formation of lysocithin-like substances by cobra venom.

Authors:  W Feldberg; C H Kellaway
Journal:  J Physiol       Date:  1938-11-14       Impact factor: 5.182

7.  The toxic proteins of cobra venom.

Authors:  P R Larsen; J Wolff
Journal:  Biochem Pharmacol       Date:  1968-04       Impact factor: 5.858

8.  [On the significance of phospholipase A for the histamine-liberating action of cobra venom].

Authors:  B May; C Holler; E Westermann
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1967

9.  Direct haemolytic activity of phospholipase A.

Authors:  P G Lankisch; W Vogt
Journal:  Biochim Biophys Acta       Date:  1972-06-19

10.  Identification of the direct lytic factor from cobra venom as cardiotoxin.

Authors:  K H Slotta; J A Vick
Journal:  Toxicon       Date:  1969-02       Impact factor: 3.033

View more
  11 in total

Review 1.  Mast cells and inflammation.

Authors:  Theoharis C Theoharides; Konstantinos-Dionysios Alysandratos; Asimenia Angelidou; Danae-Anastasia Delivanis; Nikolaos Sismanopoulos; Bodi Zhang; Shahrzad Asadi; Magdalini Vasiadi; Zuyi Weng; Alexandra Miniati; Dimitrios Kalogeromitros
Journal:  Biochim Biophys Acta       Date:  2010-12-23

Review 2.  Aspects of release of pharmacologically active substances from the lungs by chemical stimuli.

Authors:  B B Vargaftig
Journal:  Agents Actions       Date:  1976-07

3.  Effects of anti-inflammatory drugs on rat hind-paw swelling caused by phospholipase A2 from Naja naja atra venom.

Authors:  J P Wang; C M Teng
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-09       Impact factor: 3.000

4.  Evolutionary relationships and implications for the regulation of phospholipase A2 from snake venom to human secreted forms.

Authors:  F F Davidson; E A Dennis
Journal:  J Mol Evol       Date:  1990-09       Impact factor: 2.395

5.  Pharmaco-modulations of induced edema and vascular permeability changes by Vipera lebetina venom: inflammatory mechanisms.

Authors:  Fatima Sebia-Amrane; Fatima Laraba-Djebari
Journal:  Inflammation       Date:  2013-04       Impact factor: 4.092

6.  Sites of action of Mojave toxin isolated from the venom of the Mojave rattlesnake.

Authors:  P Gopalakrishnakone; B J Hawgood; S E Holbrooke; N A Marsh; S Santana De Sa; A T Tu
Journal:  Br J Pharmacol       Date:  1980-07       Impact factor: 8.739

7.  Assessing phospholipase A2 activity toward cardiolipin by mass spectrometry.

Authors:  Yuan-Hao Hsu; Darren S Dumlao; Jian Cao; Edward A Dennis
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

8.  Organic and Peptidyl Constituents of Snake Venoms: The Picture Is Vastly More Complex Than We Imagined.

Authors:  Alejandro Villar-Briones; Steven D Aird
Journal:  Toxins (Basel)       Date:  2018-09-26       Impact factor: 4.546

9.  Induction of mast cell accumulation, histamine release and skin edema by N49 phospholipase A2.

Authors:  Ji-Fu Wei; Xiao-Long Wei; Ya-Zhen Mo; Shao-Heng He
Journal:  BMC Immunol       Date:  2009-04-28       Impact factor: 3.615

10.  Revisiting the Therapeutic Potential of Bothrops jararaca Venom: Screening for Novel Activities Using Connectivity Mapping.

Authors:  Carolina Alves Nicolau; Alyson Prorock; Yongde Bao; Ana Gisele da Costa Neves-Ferreira; Richard Hemmi Valente; Jay William Fox
Journal:  Toxins (Basel)       Date:  2018-02-06       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.